Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study-Reference-Cited by-同舟云学术

Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study

Published:2022-08 Issue:10350 Volume:400 Page:431-440
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Chua Boon H,Link Emma K,Kunkler Ian H,Whelan Timothy J,Westenberg A Helen,Gruber Guenther,Bryant Guy,Ahern Verity,Purohit Kash,Graham Peter H,Akra Mohamed,McArdle Orla,O'Brien Peter,Harvey Jennifer A,Kirkove Carine,Maduro John H,Campbell Ian D,Delaney Geoff P,Martin Joseph D,Vu T Trinh T,Muanza Thierry M,Neal Anthony,Olivotto Ivo A

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Overview of the randomised trials of radiotherapy in ductal carcinoma in situ of the breast;J Natl Cancer Inst Monogr,2010

2. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS;Wapnir;J Natl Cancer Inst,2011

3. Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial;Donker;J Clin Oncol,2013

4. Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial;Wärnberg;J Clin Oncol,2014

5. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial;Bartelink;Lancet Oncol,2015

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Balancing Act: Optimizing Dose and Volume;International Journal of Radiation Oncology*Biology*Physics;2024-10

2. Boosting the Odds: Navigating Fraction Options in the Ductal Carcinoma In Situ Odyssey;International Journal of Radiation Oncology*Biology*Physics;2024-10

3. Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis;BMJ;2024-09-11

4. Update on the management of ductal carcinoma in situ of the breast: current approach and future perspectives;Japanese Journal of Clinical Oncology;2024-09-02

5. A 7-gene biosignature for ductal carcinoma in situ of the breast identifies subpopulations of HER2-positive patients with distinct recurrence rates after breast-conserving surgery and radiation therapy;Clinical Breast Cancer;2024-09